COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 1588: Articles 15871-15880  | Next

An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits potent immunity after a single dose.
Fluckiger, A.-C., Ontsouka, B., Bozic, J., Diress, A., Ahmed, T., Berthoud, T., Liao, M., Tran, A., Duque, D., McCluskie, M., Diaz-Mitoma, F., Anderson, D. E., Soare, C.
10.1101/2021.04.28.441832 — Posted: 2021-04-29
Pyridostigmine in adults with severe SARS-CoV-2 infection: the PISCO trial
Fragoso-Saavedra, S., Nunez, I., Audelo-Cruz, B. M., Arias-Martinez, S., Manzur-Sandoval, D., Quintero-Villegas, A., Garcia-Gonzalez, H. B., Carbajal-Morelos, S. L., Ponce de Leon-Rosales, S., Gotes-Palazuelos, J., Caro-Vega, Y., Maza-Larrea, J., Batina, I., Islas-Weinstein, L., Calva, J. J., Iruegas-Nunez, D. A., Belaunzaran-Zamudio, P. F., Sierra-Madero, J., Crispin, J. C., Valdes-Ferrer, S. I.
10.1101/2021.04.28.21255834 — Posted: 2021-04-29
Estimating local outbreak risks and the effects of non-pharmaceutical interventions in age-structured populations: SARS-CoV-2 as a case study
Lovell-Read, F. A., Shen, S., Thompson, R. N.
10.1101/2021.04.27.21256163 — Posted: 2021-04-29
Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study
Sagara, I., Woodford, J., Kone, M., Assadou, M. H., Katile, A., Attaher, O., Zeguime, A., Doucoure, M., Higbee, E., Lane, J., Doritchamou, J., Zaidi, I., Esposito, D., Kwan, J., Sadtler, K., Dicko, A., Duffy, P.
10.1101/2021.04.26.21256016 — Posted: 2021-04-29
Affordable and time-effective high throughput screening of SARS-CoV-2 variants using Denaturing High-Performance Liquid Chromatography analysis
Turba, M. E., Mion, D., Papadimitriou, S., Taddei, F., Dirani, G., Sambri, V., Gentilini, F.
10.1101/2021.04.27.21256156 — Posted: 2021-04-29
Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
Leier, H. C., Bates, T. A., Lyski, Z. L., McBride, S. K., Lee, D. X., Coulter, F. J., Goodman, J. R., Lu, Z., Curlin, M. E., Messer, W. B., Tafesse, F. G.
10.1101/2021.04.25.21256049 — Posted: 2021-04-29 Discussion: Onsite
Antibody response to SARS-CoV-2 infection over six months among Nicaraguan outpatients
Bucardo, F., Gonzalez, F., Zepeda, O., Toval Ruiz, C. T., Matute, A. J., Vanegas, H., Munguia, N., Centeno, E., Reyes, Y., Nordgren, J., Svensson, L., de Silva, A. M., PREMKUMAR, L., Becker-Dreps, S.
10.1101/2021.04.28.21256122 — Posted: 2021-04-29
Surging COVID-19 in Bangladesh driven by B.1.351 variant
Brum, E., Saha, S., Sania, A., Tanmoy, A. M., Hooda, Y., Tanni, A., Goswami, S., Sium, S. M. A., Sajib, M. S. I., Malaker, R., Islam, S., Sarker, N., Saha, S. K., Chowdhury, S., Haddou, Y., Ferguson, E. A., Kundegorski, M., Purno, N., Tasneem, M., Arifeen, S. E., Alamgir, A. S. M., Chowdhury, A., Hampson, K.
10.1101/2021.04.27.21255706 — Posted: 2021-04-29
Large university with high COVID-19 incidence did not increase risk to non-student population
Bharti, N., Lambert, B., Exten, C., Faust, C., Ferrari, M., Robinson, A.
10.1101/2021.04.27.21255023 — Posted: 2021-04-29
SARS-CoV-2 infections in nasal epithelial cells from smokers versus non-smokers
Essaidi-Laziosi, M., Torriani, G., Alvarez, C., Kaiser, L., Eckerle, I.
10.1101/2021.04.28.21255760 — Posted: 2021-04-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).